Thursday, March 16, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home CBRNE

Australian Blowfly Helps Advance Chemical Weapon Antidote Research

by Global Biodefense Staff
June 14, 2013

Australian Sheep Blowfly Key to Chemical Weapon TreatmentA team of scientists from the Australian National University is examining ways in which the resilient Australian sheep blowfly, a pest that has proven highly resistant to insecticides, may also pave the way to an antidote for chemical warfare agents. 

“The Australian sheep blowfly has been exposed to organophosphates for decades and now produces a mutated protein, called alpha-esterase-7, which has evolved to soak up and detoxify the organophosphate, so flies can now survive being sprayed,” said Dr. Colin Jackson of the Research School of Chemistry.  “The silver lining in the development of insecticide resistance in blowflies is that nature might have created a potential treatment for human organophosphate poisoning.”

Organophosphates are commonly used insecticides that act by blocking nerve signals in insects. An estimated hundreds of thousands of human fatalities globally occur every year as a result of organophosphate poisoning.

“Even with the very best treatment, the mortality rate for organophosphate poisoning is quite high and we really need more effective treatments,” said Jackson. Chemical weapons using organophosphate-based nerve agents, such as sarin gas or VX, are similarly very difficult to treat. 

With funding from the U.S. Defense Threat Reduction Agency (DTRA) and in collaboration with CSIRO, the research team took the gene for the organophosphate resistant protein from the blowfly and engineered it so that large amounts of the protein could be produced in the bacterium Escherichia coli. 

The team was then able to produce large amounts of the resistance protein, form them into crystals and analyze how X-rays were scattered by the crystal to determine the protein’s structure. 

Beyond enabling design of more effective pesticides and treatments for humans with pesticide poisoning, the mutated protein is now being studied for the potential of creating a novel antidote for victims of chemical warfare agents. 

Source: Adapted from Australian National University

Tags: Defense Threat Reduction Agency

Related Posts

DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
How Are Bivalent COVID Vaccines Stacking Up Against Omicron?
Infectious Diseases

How Are Bivalent COVID Vaccines Stacking Up Against Omicron?

January 12, 2023
NISTCHO: New Living Reference Material for Producing Monoclonal Antibodies
Medical Countermeasures

NISTCHO: New Living Reference Material for Producing Monoclonal Antibodies

January 12, 2023
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC